Vancomycin resistant Enterococcus faecium (VREfm) is an emerging antibiotic resistant 38 pathogen. Strain-level investigations are beginning to reveal the molecular mechanisms used 39 by VREfm to colonize regions of the human bowel. However, the role of commensal bacteria 40 during VREfm colonization, in particular following antibiotic treatment, remains largely 41 unknown. We employed amplicon 16S rRNA gene sequencing and metabolomics in a murine 42 model system to try and investigate functional roles of the gut microbiome during VREfm 43 colonization. First-order taxonomic shifts in gut microbial community composition were 44 detected both in response to pretreatment using ceftriaxone, and to subsequent VREfm 45 challenge. Using neural networking approaches to find co-occurrence profiles of bacteria and 46 metabolites, we detected key metabolome features during and after VREfm colonization. These 47 offer insights towards identifying potential non-antibiotic alternatives to eliminate VREfm 51 through metabolic re-engineering to preferentially select for Bacteroides. 52 53 Importance 54
metabolite features were associated with Bacteroides, indicative of a transition towards a pre-48 antibiotic naïve microbiome. This study shows the impacts of antibiotics on the gut ecosystem, 49 and the progression of the microbiome in response to colonisation with VREfm. Our results
Introduction 62
Vancomycin-resistant Enterococcus faecium (VREfm) is a significant healthcare-associated 63 pathogen. VREfm infections can be difficult to treat due to their intrinsic and acquired 64 resistance to nearly all classes of antibiotics (1) . The World Health Organisation categorizes 65 VREfm as a "High Priority" bacterial pathogen, advocating research to stop the global increase 66 in antibiotic resistance (2) . Recent studies highlight the importance of the gut microbiota in 67 modulating the growth and virulence of VREfm in the gastrointestinal ecosystem. For instance, 68 the depletion of normal gut flora using antibiotics exacerbates the severity of VREfm infection 69
(3), whereas transplant of commensal species including a consortium of Clostridium bolteae, 70 have gastrointestinal tracts that are dominated by VREfm as a result of losing a large portion 78 of the intestinal commensal microbiota upon receiving broad-spectrum antibiotics as pre-79 treatment (7) . Hildebrand et al., (2018) discovered long-term ecological impacts to the gut 80 microbiome, with strong bacterial species turnover, after ceftriaxone treatment in humans (8) . 81
Further, mice receiving broad spectrum antibiotics (combination of metronidazole, neomycin, 82 and vancomycin) showed markedly increased VREfm colonization of the caecum and colon. 83
The compromised intestinal innate immune defenses in these animals allowed proliferation of 84 VREfm caused by the antibiotic exposure and subsequently reduced the expression of 85 antimicrobial molecules produced by bacteria in the intestinal mucosa (9) . 86
The problem with VREfm is further complicated by the fact that Enterococci are 87 members of the gastrointestinal tract microbiota; a key reservoir of antimicrobial resistance 88 (AMR) genes, and potentially facilitating gene transfer within the gut microbiome(10). For 89 example, the vanB resistance gene was detected in human faecal specimens that did not contain 90 culturable VRE; and instead, demonstrated that isolates carrying the resistance transposon are 91 anaerobic commensal bacteria, Eggerthella lenta and Clostridium innocuum (11) . Colonisation 92 of, and persistence in, the gastrointestinal tract therefore presents as a key mechanism for de 93 novo VRE and may lead to severe invasive disease. 94 95 This current study aimed to understand the impact of antibiotics on the murine gut microbiota, 96 and the subsequent colonisation pattern of VREfm. To this extent, we designed a murine model 97 time-series study that consisted of two main perturbative phases: (1) antibiotic pre-treatment 98 with ceftriaxone, and (2) VREfm challenge. Our 16S rRNA profiling analyses highlighted a 99 first-order shift in bacterial biodiversity composition across time, a second-order clustering of The murine gut microbiota responds to antibiotics and microbial community richness begins 137 to rebound three-days post-VRE colonisation 138
Principal coordinate analysis (PCoA) of the unweighted UniFrac(12) distances was used to 139 assess clustering of fecal samples based on bacterial composition. This assessment showed that 140 the fecal microbiota from samples collected from each phase clustered together but were 141 clearly separated between phases; after exposure to ceftriaxone, and challenge with VREfm 142 post-antibiotic treatment (Figure 2A ). Permutation-based statistical testing demonstrates the 143 groups are significantly different from one another ( Supplementary Figure 2) . Temporal 144 tracking of the changing microbiomes against each mouse on the PCoA sample-space 145 demonstrated a clear, unidirectional trajectory that followed the chronology of the experiment 146 (animation as a supplementary file). Procrustes analyses of weighted and unweighted UniFrac 147 distances showed that the same general patterns on the sample space were preserved, meaning 148 that there is congruency in global spatial patterns between qualitative and quantitative measures stable and rich microbial community during the naïve phase preceding a sharp decrease 152 following antibiotic treatment, and a further decrease immediately following VREfm 153 colonisation ( Figure 2B ). Of note is the responsiveness of the microbiota (within 24 hours) to 154 the removal of antibiotics at the end of day 7. Community richness began to rebound at 155 approximately three-days post-VREfm colonisation (i.e., day 12), with Group A demonstrating 156 a faster rate of rebound compared to Group B and C. Calculating the distances of dissimilarity 157 (unweighted UniFrac distances) of each mouse microbiota timepoint relative to Day 0 (a proxy 158 for the naive bacterial community phenotype) revealed a small dissimilarity distance for 159 samples collected during the naïve phase, and an increasing dissimilarity distance following 160 antibiotic treatment (day 6) and VREfm colonisation (day 9; Figure 2C ). There was a 161 downward trajectory in distance scores at three-days post-VREfm colonisation (i.e., day 12); 162 Group A followed a sharper return to a microbiota resembling day 0. These observations 163 suggest that mice were transitioning towards a persistent carrier-like state, and that the 164 rebounding community richness towards levels representative of the naïve phase was by a 165 microbial community structure that resembled the naïve phase. Additional studies, where the 166 time-frame post-VREfm challenge extends beyond one-week of monitoring, are needed. 167
168
Multinomial regression identifies sOTUs most positively associated with VREfm colonisation 169
Multinomial regression using Songbird was employed to identify sOTUs that were most 170 positively, and negatively, associated with the post-VREfm colonisation phase ( Figure 3 ). The colonisation phase -was most abundant on days of challenge; confirming that this ESV likely 177 was the ST796 VREfm colonization challenge organisms. There were a further eight ESV 178 features classified as Enterococcus, however, they were absent during the days representing 179
VREfm colonisation, and lacked positive associations with the post-VREfm colonisation 180 phase, suggesting that these features represent murine gut commensal Enterococci. 181 182 Molecular networking identifies differential metabolome profiles 183 Duplicate fecal samples from key timepoints throughout the experiment (i.e., days 0, 5, 6, 7, 8, 184 9, and 14) were analysed by data dependent tandem mass spectrometry (MSMS) performed on 185 a liquid-chromatography quadrupole time-of-flight (LC-QTOF) to monitor changes in the 186 murine gut metabolome ( Table 1) Figure 5 ). Shallow neural networking analysis with mmvec was used to predict microbe-208 metabolite interactions through their co-occurrence probabilities ( Figure 5 ). Sequential biplots 209 captured the shift in experimental phases and highlighted the co-occurrences of microbiota and 210 metabolomic datasets ( Fig. 5A,B ). There was a strong Enterococcus effect as indicated by the 211 magnitude of the corresponding arrow, and the rebounding species during the late-phase 212
VREfm colonisation are predominantly Bacteroidales sOTUs ( Figure 5C In this study of the murine gut ecosystem, we employed a mouse model of gastrointestinal tract 222 colonisation that replicates the shift in bacterial composition when patients enter the healthcare 223 system, develop an imbalance in microbiome as a result of pre-treatment (e.g., antibiotic 224 treatment), and are subsequently colonised with a hospital superbug (14). The resolution of current studies describes a consortium of commensal microbes that can, for example, reduce 226 the magnitude of VREfm colonisation (4, 6); however, understanding the key metabolic shifts 227 relative to the gut microbiota remains challenging (15). Here, we employed amplicon 16S 228 rRNA gene sequencing and high-resolution mass spectrometry metabolomics in an effort 229 towards determining microbiota-metabolome interactions during VREfm colonisation. We 230 demonstrated clear changes in the gut microbiome in response to ceftriaxone and VREfm 231 challenge. 232 233 Conceptual and statistical advances in analysis of amplicon 16S rRNA gene data (16, 17) 234 whereby OTUs are clustered at a 99% nucleotide similarity threshold allows for the 235 identification of exact sequence variants (ESV). Query against an error-corrected database 236 (17)can detect multiple ESVs that may be classified to the same taxonomic rank. For example, 237 our analyses identified multiple ESVs classified as Enterococci; however, when the relative 238 abundances were tracked across the chronology of the experiment, only one Enterococci-ESV 239 was dominant in relative abundances and most positively associated with the days of post-240 VREfm challenge. This highlights the resolving power to differentiate between commensal and 241 pathogenic strains of Enterococci when the composition of the microbial community is 242 considered. The fact that this was achievable at the level of amplicon 16S rRNA gene 243 sequencing alludes to the possibility of implementing microbiota screenings as routine 244 diagnostics for patients entering healthcare systems. Further, first-order level shifts in 245 microbial community composition was observed in response to ceftriaxone and subsequent 246 VREfm challenge (Figure 1 ). At three days post-VREfm colonisation (i.e., day 12), the 247 microbiome richness begins to rebound; suggesting that mice are transitioning towards a 248 persistent carrier-like state. Interestingly, Group A cohort exhibited a faster rate of rebound 249 that may be facilitated by their initially higher microbial community richness ( Figure 2B ); this observation supports the need to prescreen "baseline" microbiota profiles of patients upon 251 admission into hospitals. We can begin to assess patients from across different wards (e.g., 252
intensive care unit, oncology, neurology, and healthy cohorts), and build a database of 253 microbiome profiles that can be used as biomarkers to predict: (1) Sequence data were processed within the QIITA framework for quality control (split libraries), 311 demultiplexing, trimming sequence reads to a length of 150 nt, and picking sub-operational 312 taxonomic units (sOTUs) using Deblur to resolve single-nucleotide community sequencing 313 patterns (i.e. feature identification of sOTUs;(17)). The output BIOM files were further 314 processed using QIIME2 for downstream statistical analyses(22). Alpha rarefaction curves 315 were generated to determine if each sample had been sequenced to saturation; the feature table  316 was subsequently rarefied to 20,000 reads per sample. Taxonomy was assigned using the 317 sklearn classifier (23) and Greengenes 13.8 99% OTUs from 515F/806R region of sequences 318 classifier available from https://docs.qiime2.org/2018.4/data-resources/. Furthermore, relative 319 abundances of each taxa were visualized as bar plots using the QIIME2 taxa plugin. A 320 phylogenetic tree was constructed using fragment-insertion (QIIME fragment-insertion sepp; 321 (24)) to guide phylogenetic-aware statistical analyses generated using the QIIME2 plugin, q2-322 diversity core-metrics-phylogenetic; key metrics computed by default include both alpha-323 diversity (e.g., Shannon's diversity index, Faith's phylogenetic diversity, and Evenness), and 324 beta-diversity (e.g., Bray-Curtis distance, and unweighted UniFrac distances) metrics. The distances relative to Day 0 as baseline between sequential states (QIIIME longitudinal first-327 distances); ggplot2 (R, https://ggplot2.tidyverse.org) was used to visualize the distance scores 328 as line plots. Emperor was used to visualize principal coordinate analysis plots of unweighted 329 UniFrac distances. Permutation-based statistical testing (PERMANOVA) on unweighted 330
UniFrac distances was used to determine if samples grouped by phase of experiment were 331 significantly different from one another (q2-beta-group-signifcance). Songbird 332 (https://github.com/mortonjt/songbird) was employed to determine the importance (i.e., fold 333 change) of each sOTU in relation to a given metadata variable (e.g., VREfm-colonisation). 334
Microbial features from all samples were split into training and test sets for supervised learning 335 classifier analyses; 20% of input samples were allocated to train the Random Forest Classifier 336 within QIIME2, the estimator method used for sample prediction. The different experimental 337 phases were the response variables, while the 16S rRNA gene data (and metabolomic spectra) 338 were the features. 339 340
Metabolite extraction and liquid chromatography tandem mass-spectrometry analysis 341
Duplicate fecal samples, as outlined in Table 1 , were processed for polar metabolite extraction 342 and analysis (days 0, 5, 6, 7, 8, 9, and 14) . 
Metabolomic analyses 359
The data-dependent tandem MS data was processed using MZmine2 (26) to generate tabular 360 matrices of metabolite features. Metabolomic features were further analysed within the Global 361 Natural Products Social Networking (GNPS; (13)) framework (UCSD, CA, USA). Tandem 362 MS data were processed for identification, dereplication and quantification, including spectral 363 library searches. For example, MS2 spectra of the unknown metabolites are compared with a 364 library of MSMS spectra generated from structurally characterized metabolites. Further 365 information on the GNPS workflow, and molecular networking can be found in Ming et al., 366 2016 (13) . 367 368
Neural networking to predict microbe-metabolite interactions 369
Microbiota and metabolome feature tables were analyzed using MMVEC 370 ((27)https://github.com/biocore/mmvec) to identify microbe-metabolite interactions through 371 their co-occurrence probabilities as predicted by neural networking. Conditional biplots were 372 generated using Emperor. Further, microbe abundances and metabolite log centered abundance heatmaps were generated using primary derived data from multinomial regression analyses 374 using Songbird (https://github.com/mortonjt/songbird). 375 376 Acknowledgements 377
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Dr. Daniel Petras (UCSD) for helpful discussions. First-order shifts in microbial community composition, as revealed by 16S rRNA community 587 profiling, from a predominance of Bacteroidetes to Tenericutes and return to Bacteroidetes was 588 observed. Each column displays the relative bacterial community composition in a mouse 589 faecal sample collected at daily intervals, and sorted by the chronology of the experiment (i.e., 590 Day of experiment; Table 1 ). 'M-A1' notation refers to the box and mouse number; for 591 example, M-A1 is mouse 1 in Group A, while M-B2 is mouse 2 in Group B. The colors 592 represent different bacterial classes, including Bacteroidia (green), Clostridia (grey) 593
Tenericutes (Mollicutes; pink), Bacilli (brown), and gamma-Proteobacteria (yellow). 594 
